user avatar
Guerbet Group
@GuerbetGroup
At Guerbet, we build lasting relationships so that we enable people to live better. This is our Purpose. #OurPurpose #HumanCooperation #EnablePeopleToLiveBetter
Paris - Worldwide
Born November 15, 1926
Joined June 2010
  • user avatar
    ๐Ÿ“ฃ MEET THE EXPERT! Interact live with Prof. Geert Maleux and know everything about the Lymphangiography Technique in less than 30 minutes. ๐ŸŽ™๏ธ Talk: 20 minutes I โ˜๏ธ Q&A: 10 minutes Register here ๐Ÿ‘‰ bit.ly/3yKhg1R #knowledgesharing #IRad #ET2021
  • user avatar
    [Liver awareness month]๐ŸŽฅWhat symptoms should alert patients to the possibility of developing an HCC? Early detection can save lives. Watch this video with Dr @BargelliniIrene, radiologist from university of Pisa, to learn about the key signs to look out for in hepatocellular
    00:00
  • user avatar
    ๐ŸŽฅWhat types of patients are most at risk of developing HCC today? Understanding the risk factors of hepatocellular carcinoma (HCC) can make a difference. Learn more in our latest video.๐Ÿ‘‡ #LiverHealth #HCCRisk #LiverCancer
    00:00
  • user avatar
    Dr Ian McCafferty says that, the public needs to be informed about this hidden gem called image guided surgery (IR) and start to demand access to these safe, cost effective low risk procedures on this #WithoutAScapelDay2021 Read more โžก๏ธ bit.ly/3bIA20o #IRad
  • user avatar
    Learn more about how to improve HCC management and streamline patient pathway through diagnostic & treatment process with our chairpersons and speakers Prof. Valรฉrie Vilgrain (Clichy, France) and Prof. Gรถtz M. Richter (Stuttgart, Germany) ๐Ÿ‘‰ bit.ly/3AA1pmU #CIRSE2021
  • user avatar
    Guerbet continues to celebrate all the #WomeninIR on this International Women's Day! See below what Dr. Elika Kashef @grounds4riots says Learn more โžก๏ธ bit.ly/2PFoORn #HerTimeisNow #IWD2021 #ChooseToChallenge
  • user avatar
    ๐ŸŽฅ What is the typical care pathway for an HCC patient? ๐Ÿ’ก From diagnosis to treatment, understanding the journey of hepatocellular carcinoma (HCC) care is crucial for patients and caregivers. Watch our video for more insights. ๐Ÿ‘‡ #CancerCare #HCCJourney #LiverCare
    00:00
  • user avatar
    Re-birth of Trans pedal & Trans nodal Lymphangiography: Interact live with Dr. Christof-Matthias Sommer & Dr. Claus Pieper (Germany) who will share their knowledge on that procedure. ๐Ÿ‘‰ bit.ly/3AA1pmU #CIRSE2021 #knowledgesharing
  • user avatar
    ๐ŸŽฅ New video: What measures can be taken to help caregivers? ๐Ÿ”Ž Caregivers play a vital role in supporting HCC patients. Learn who can help them and how in this video. ๐Ÿ‘‡ #CaregiversSupport #LiverCancerCare #HCC
    00:00
  • user avatar
    ๐ŸŽฅ What therapeutic advances can we expect in the coming years? ๐Ÿ’ก The future of HCC treatment is promising. Explore the expected therapeutic breakthroughs in hepatocellular carcinoma. #MedicalInnovation #HCCResearch #LiverCancerAdvances
    00:00
  • user avatar
    No stitches. No scars. Yesterday was National #WithoutAScalpel Day! On this day in 1964, Father of Interventional Radiology Charles Dotter performed the first peripheral angioplasty. ๐Ÿ‘‚ Listen to Dr. Christopher Rogan's perspective on the #minimallyinvasive approach. #IRad
    00:00
  • user avatar
    Today is #WorldCholangiocarcinomaDay, an international day to raise awareness around #cholangiocarcinoma (CCA), a rare but aggressive and deadly cancer. Learn more about our involvement in the management of #CCA ๐Ÿ‘‰ bit.ly/36a1pzS #WorldCCADay @WorldCCADay
  • user avatar
    Interact LIVE with Prof. Geert Maleux on the Lymphangiography Technique session. Pick the slot that works best for you! #knowledgesharing Learn more and register for free โžก๏ธ bit.ly/31F22f9
  • user avatar
    Weโ€™re thrilled to announce Food and Drug Administration (FDA) approval of our new contrast agent used for magnetic resonance imaging (MRI) ๐Ÿ‘‰ prn.to/3DINhw0